Cannabis-only use in the USA: prevalence, demographics, use patterns, and health indicators
Open Access
- 22 July 2022
- journal article
- research article
- Published by Springer Nature in Journal of Cannabis Research
- Vol. 4 (1) , 1-8
Abstract
Background: The prevalence of adults who consume cannabis while abstaining from other substances is not known in the USA. This study used nationally representative data to estimate the prevalence and explore the demographic characteristics, cannabis use behaviors, and self-reported health of US adults with past 30-day cannabis-only use, as compared with adults who used cannabis as well as other substances. Methods: Data came from adults 18 years and older who responded to the 2017 or 2018 National Survey on Drug Use and Health and reported past 30-day cannabis use (n = 12,143). Cannabis-only use was defined as past 30-day cannabis use with no past 30-day use of other substances (alcohol, tobacco, other illicit substances, non-prescribed controlled medications). Weighted frequencies and 95% confidence intervals (CI) were computed for all sociodemographic and cannabis-related variables, overall, and across the two categories of cannabis consumers, stratified by age. Results: The prevalence of past 30-day cannabis-only use among US adults was 0.9% (95% CI: 0.8, 1.0) and varied by age (2.0% of 18–25 years old; 0.7% of 26–49 year olds, and 0.6% of those ≥ 50 years). Among adults with any past 30-day cannabis use, 8.4% (95% CI: 7.6, 9.2; n = 980) reported cannabis-only use. Age was significantly associated with past 30-day cannabis-only use, with adults 18–25 years and 26–49 years having higher odds of cannabis-only use compared with older adults. Past year cannabis dependence was lowest among cannabis-only consumers aged ≥ 50 years (0.2%; 95% CI: 0.1, 0.5) and highest among young adult cannabis and other substance consumers (16.7%; 95% CI: 15.3, 18.2). Past year prevalence of any mental illness was generally similar across cannabis use groups and by age. Conclusions: The prevalence of adult cannabis-only use in the US is low — most cannabis consumers report using other substances in the past 30 days as well. While cannabis-only use among older adults is rare, it does not appear to be accompanied by a high prevalence of dependence. These findings should guide future research and policymaking.Keywords
Funding Information
- State of Washington Cannabis Dedicated Fund to the University of Washington (2021)
This publication has 21 references indexed in Scilit:
- Association of Noncigarette Tobacco Product Use With Future Cigarette Smoking Among Youth in the Population Assessment of Tobacco and Health (PATH) Study, 2013-2015JAMA Pediatrics, 2018
- Cannabis as a substitute for prescription drugs – a cross-sectional studyJournal of Pain Research, 2017
- Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patientsInternational Journal of Drug Policy, 2017
- The Health Effects of Cannabis and Cannabinoids2017
- Cannabis as a Substitute for Opioid-Based Pain Medication: Patient Self-ReportCannabis & Cannabinoid Research, 2017
- Drug Use Patterns and Continuous Enrollment in College:Results From a Longitudinal StudyJournal of Studies on Alcohol and Drugs, 2013
- Cannabis as an Adjunct to or Substitute for Opiates in the Treatment of Chronic PainJournal of Psychoactive Drugs, 2012
- Developing the World Health Organization Disability Assessment Schedule 2.0Bulletin of the World Health Organization, 2010
- Marker or mediator? The effects of adolescent substance use on young adult educational attainmentAddiction, 2006
- Alcohol and Public Policy1981